Subscribe
cancer
wildpixel / iStockphoto.com
5 September 2017Americas

Kite accused of infringing Juno’s cancer immunotherapy

Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have entered a second round of litigation against Kite, a company which specialises in cancer immunotherapy treatments.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Life sciences companies face off over ‘Juno’ trademark
26 July 2017   Clinical-stage biotech company Juno Therapeutics has not taken kindly to another business using its name.
Americas
Kite teams up with Sangamo to treat cancer
26 February 2018   Kite Pharma has entered into a collaboration with Sangamo Therapeutics that will see the companies develop next-generation engineered cell therapies to treat cancer.
Biotechnology
Gilead fails to overturn $752m BMS patent verdict
2 April 2020   A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Americas
Life sciences companies face off over ‘Juno’ trademark
26 July 2017   Clinical-stage biotech company Juno Therapeutics has not taken kindly to another business using its name.
Americas
Kite teams up with Sangamo to treat cancer
26 February 2018   Kite Pharma has entered into a collaboration with Sangamo Therapeutics that will see the companies develop next-generation engineered cell therapies to treat cancer.
Biotechnology
Gilead fails to overturn $752m BMS patent verdict
2 April 2020   A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies.

More on this story

Americas
Life sciences companies face off over ‘Juno’ trademark
26 July 2017   Clinical-stage biotech company Juno Therapeutics has not taken kindly to another business using its name.
Americas
Kite teams up with Sangamo to treat cancer
26 February 2018   Kite Pharma has entered into a collaboration with Sangamo Therapeutics that will see the companies develop next-generation engineered cell therapies to treat cancer.
Biotechnology
Gilead fails to overturn $752m BMS patent verdict
2 April 2020   A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers